Meeting current and future serialization challenges
A white paper from Aesica, a leading pharmaceutical contract development and manufacturing organization (CDMO) for both APIs and finished dosage forms.
Serialization has emerged as a complex challenge for the pharmaceuticals sector,, which is facing a multiplicity of differing regulations that vary from one country to another. Several countries including China, South Korea, Turkey, Argentina and Brazil already have regulations in place that must be complied with, whilst many others, including countries in the EU, face pending requirements.
For a copy of this white paper, please click here:
